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The corepressor SMRT acts on a range of transcription factors, including the retinoid and thyroid hormone nuclear receptors. The carboxy-
terminal region of SMRT contains CoRNR box motifs that mediate these interactions. We have shown, in Xenopus, that SMRT can exist as
isoforms containing either two or three CoRNR boxes depending on the alternative splicing of exon 37b. The number of SMRT transcript isoforms
expressed increases during development until all sixteen possible isoforms are identified in the swimming tadpole. To eliminate specific SMRT
isoforms, we have developed a process that uses an antisense morpholino oligonucleotide in Xenopus to dictate the outcome of alternative splicing
at a defined exon and used this to inhibit the formation of transcripts containing exon 37b. These embryos are therefore limited to the expression of
SMRT isoforms that contain two rather than three CoRNR boxes. Analysis of responsive genes in these embryos shows that targets of thyroid
hormone, but not retinoid signaling are affected by the elimination of exon 37b. Morpholino-injected embryos have swimming abnormalities and
develop altered head morphology, an expanded olfactory epithelium and disorganized peripheral axons. These experiments indicate a critical role
for the alternative splicing of SMRT in development.
© 2006 Elsevier Inc. All rights reserved.Keywords: Alternative splicing; Morpholino oligonucleotides; Nuclear receptors; SMRT corepressor; XenopusIntroduction
SMRT is a corepressor of transcription factors that include
AP-1, NF kappa B, serum response factor and class II nuclear
receptors such as specific isoforms of the retinoic acid and
thyroid hormone receptors (reviewed in Jepsen and Rosenfeld,
2002; Farboud et al., 2003). The nuclear receptors mediate
signaling in response to ligands (Mangelsdorf et al., 1995) but,
in the absence of ligand, they interact with corepressors such as
SMRT, or its paralogue N-CoR, which then assemble a
multiprotein complex containing histone deacetylases that can
put chromatin into an inactive state (Li et al., 2000). In the
presence of ligand, the corepressor is displaced and coactiva-
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doi:10.1016/j.ydbio.2006.01.007recruited to stimulate transcription (Glass and Rosenfeld,
2000; Kraus and Wong, 2002).
Repression of nuclear receptor activity by SMRT and
NCoR is important in development. The targeted elimination
of the mouse NCoR gene results in embryonic lethality,
before which the animals develop defects in CNS and blood
cell development (Jepsen et al., 2000). In addition, neural
stem cells from these mice show impaired self-renewal and
altered differentiation (Hermanson et al., 2002). The gener-
ation of these phenotypes indicates that the activities of
NCoR and SMRT are not redundant. In Xenopus, the
expression of an amino-terminal, truncated, murine SMRT,
which has dominant negative activity (Chen and Evans,
1995), reduces the expression of anterior markers. The
resulting embryos show severe anterior truncations, a
phenotype similar to that seen following exposure to excess
retinoic acid or the removal of RARα using an antisense
morpholino oligonucleotide, indicating a requirement for the
active repression of RA signaling by SMRT for normal head
development (Koide et al., 2001).
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tional repressor domains (RDs) (Chen and Evans, 1995;
Horlein et al., 1995; Ordentlich et al., 1999) and in the less-
conserved carboxy-terminal region have interaction domains
that mediate binding to nuclear receptors through CoRNR box
motifs of the sequence I/L.x.x.I/V.I. (Hu and Lazar, 1999;
Perissi et al., 1999; Nagy et al., 1999). Regions adjacent to
these motifs contribute to their different affinities for nuclear
receptors (Cohen et al., 2001; Hu et al., 2001; Makowski et
al., 2003). Three CoRNR boxes have been identified in NCoR
(Webb et al., 2000), but until recently, only two have been
found in SMRT. However, the SMRT gene encodes a third
CoRNR box motif (box-3) that can be included in the
transcript by alternative splicing following readthrough of the
conventional splice donor at the end of exon 37. This allows
SMRT to exist as two-box and three-box isoforms (Malartre et
al., 2004). The diversity of SMRT isoforms is extended by the
alternative splicing of exon 44 in mouse and humans that
generates a SMRT isoform with just one CoRNR box (Short
et al., 2005).
In addition to the inclusion of an extra CoRNR box, we
have identified three further sites of alternative splicing in the
Xenopus SMRT transcript (Malartre et al., 2004). Two of
these (exons 41 and 42b) alter the distance between CoRNR
boxes and the third (exon 44b) alters the flanking region of
CoRNR box-1 (Chen and Evans, 1995; Ordentlich et al.,
1999; Malartre et al., 2004). SMRT lacking exon 44b has also
been called SMRTτ (Goodson et al., 2005). Consequently,
each alternative splicing event has the potential to modify the
ability of SMRT to interact with nuclear receptors and this
has been demonstrated in vitro for SMRTτ, which binds
TRβ1 and TRα with reduced affinity on the lysozyme F2
promoter compared to the 44b(+) form (SMRTα) (Goodson et
al., 2005). However, to analyze the contribution of individual
SMRT exons to development it will be necessary, systemat-
ically, to manipulate alternative splicing. In this paper, we
examine the function of the SMRT isoforms that express the
CoRNR box encoded by exon 37b. We show that the
alternative splicing of this exon occurs widely throughout the
embryo and that the complexity of the repertoire of SMRT
transcript isoforms increases during development. Using a
specific antisense morpholino oligonucleotide (MO) that
spans the splice donor sequence of exon 37b, we can
eliminate this exon from SMRT transcripts. The loss of
exon37b affects the expression of thyroid hormone, but not
retinoic acid-responsive genes and generates embryos with
defects in head, olfactory epithelium and peripheral nerve
development.
Materials and methods
Animals
Xenopus laevis and tropicalis embryos were grown in 0.1×MBS as
described (Gurdon, 1977) and X. tropicalis were maintained at 23–25°C.
Embryos were staged according to Nieuwkoop and Faber (1967). For in situ
hybridization, the vitelline membrane was removed and the embryos fixed in
MEMFA. Dissections were performed in 1×MBS.RT-PCR and quantitative RT-PCR
RNA was extracted from Xenopus embryos or tissues and converted to
cDNA using Superscript II reverse transcriptase (Invitrogen). Unless otherwise
stated, PCR reactions were for 32 cycles at an annealing temperature of 53°C.
The following primers were used to amplify exon 37b: primer 1 5′
TCCATGCAAGAACAGGAG 3′, primer 2 5′ AATGGCACGGTGACTGTT
3′. Primer 2 was also used in combination with primer 3 5′ TAAGACCAC-
CATGACTGC 3′ from within the exon 37b sequence to amplify 37b(+)
transcripts or primer 4 5′CGTTCACTCGGATTCCCT 3′ that spans to exon 37/
38 boundary in the 37b(−) cDNA clone to amplify 37b(−) specific transcripts.
The corresponding primers for X. tropicalis are: Primer 1t 5′ TCCATGCAG-
GAACAGGAG 3′, Primer 2t 5′ CATGACATGGTGATTGTT 3′, Primer 4t 5′
CGATCACTCGGATTCCCT 3′. ODC primers are as described (Steer et al.,
2003). The expression of exon 44b in Xenopus was examined using primers
Alt15 5′ ACAGCAACATGGGATTGG 3′ and Alt16 5′ GAGTCTTCCTGTTG-
CAGTC 3′ that lie adjacent to exon 44b.
The following oligonucleotides were used to analyze targets of retinoid
signaling:
HoxD1 forward 5′ CAGCCCCGATTACGATTATTATGG 3′
reverse 5′ CCGGGGAGGCAGGTTTTG 3′
cyp26 forward 5′ GCTGCCACGTCCCTCACCTCTT 3′
reverse 5′ GCCGATGCAGCACCTCACTCCA 3′
Hoxb4 forward 5′ ATAGCCTCAGACCACAAGCACC 3′
reverse 3′ CAAAGTGTGCGCAATTTCCA 3′
Hoxb7 forward 5′ GAGTGTTCCCAGAGCAAA 3′
reverse 3′GGCGAGCAGTGCATATTG 3′.
Targets of thyroid hormone signaling were analyzed using the following
oligonucleotides:
TRβ forward 5′ TGCCATGTGAAGACCAGA 3′
reverse 5′ AGGCGACTTCGGTATCAT 3′
THbzip forward 5′ AGCTGAGGTTTAAGGGAG 3′
reverse 5′ TAAATGTGCCACCTCTGC 3′
BMP4 forward 5′ GAGATTGTCCATTTCCCTTGGC 3′
reverse 3′ TCAGTGGAAAGAAGTCCAGCCC 3′
Stromelysin-3 forward 5′CTGGGACAAGACAAACCT 3′
reverse 5′ GCAGCTACTTGAAGTAGG 3′.
For other targets the following oligonucleotides were used:
ACTC forward 5′ CATACCAATGAAGGATGGCTGG 3′
reverse 5′ TACTGCTGAGCGTGAAATGCTG 3′
Gyk forward 5′ CAATTGACCAAGGCACGA 3′
reverse 5′ TACAGAGGCTCTCCTGTT 3′
His H4 forward 5′ CGGGATAACATTCAGGGTATCACT 3′
reverse 3′ ATCCATGGCGGTAACTGTCTTCCT 3′.
These PCR products were resolved on 2% agarose gels run in 1× TBE.
Transcript profiles were generated using end labeled SMRT oligonucleotide
Alt16 and unlabelled SMRT oligonucleotide Alt12 in RT-PCR (Malartre et al.,
2004) and the products resolved on 6% denaturing acrylamide gels, viewed and
quantified by phosphorimager. Xenopus laevis sequences were cloned from the
PCR products using the TOPO TA cloning kit (Invitrogen) and characterized by
automated sequencing (Lark Technologies Inc.).
Quantitative RT-PCR was used to determine the levels of mRNA containing
the constitutively spliced exon 37 and levels of mRNA containing the
alternatively spliced exon 37b using a common upstream primer (37f1) and
exon specific downstream primers (37r1 and 37br2). Reactions were performed
in triplicate using a TAMRA double-labeled fluorescent probe (37pro) with
Abgene Absolute master mix on an ABI Prism 7900HT real-time pcr machine.
The data were analyzed by the comparative CT method (ΔΔCT) (ABI) for
relative quantitation of gene expression, using the expression of ODC as
reference (Scarlett et al., 2004) and control morpholino oligonucleotides (Guille
and Brickwood, unpublished data and Gene Tools, LLC, standard control
Fig. 1. SMRT is expressed predominantly in the head and somites of the
tailbud Xenopus embryo. (A, B) In situ hybridization of gastrula stage
embryos using (A) sense and (B) antisense SMRT RNA probes. (C) Dorsal
view of a wholemount in situ hybridization of an early tailbud embryo (stage
26) using an antisense SMRT probe (anterior to right). There is significant
staining in the head and posterior floorplate (Fp). Lateral stripes correspond to
the position of the somites (Sm) and expression is also seen in the posterior
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morpholino oligonucleotide, MO37b described below.
37f1: 5′ GACCAGTCTACAGTGTCAGCCATT 3′
37r1: 5′ TTCTTGCATGGAAAAGGGTTTAA 3′
37br2: 5′ GAAGTTGGCCGCAGTCATG 3′
37pro: 5′ AGCAGCACAATAGGGACAAGACCCCA 3′.
Injection of morpholino oligonucleotide MO37b
3 to 30 ng (in 2 nl) of antisense morpholino oligonucleotide (Gene Tools,
LLC) spanning the X. tropicalis exon 37b splice donor (in bold) 5′
GTATGTCTTACCATCACTATTGGCG 3′ (MO37b) was injected into X.
tropicalis embryos grown in 1× MBS, 3% ficoll at the one cell stage. After two
h, embryos were transferred and grown in 0.1× MBS at 23–25°C until the
required stage for assay. Xenopus laevis embryos were injected at the one-cell
stage with up to 30 ng of either MO37b or GeneTools control MO in 10 nl and
grown as for X. tropicalis but at 17–23°C. RT-pcr analysis showed that 30 ng of
MO37b eliminated exon 37b from X. laevis embryos (data not shown).
Phenotype analysis
In situ hybridization was performed as described (Harland, 1991, with the
amendments of Baker et al., 1995), using a Sox-2 probe (Mizuseki et al., 1998).
Sectioned embryos were stained with Hoechst (Eagleson and Harris, 1990) to
identify nuclei and photographed under a Nikon fluorescence microscope.
Whole-mount immunohistochemistry with the anti-HNK1 antibody (Sigma)
was as described (Sharpe and Goldstone, 1997). To identify cartilage, MEMFA
fixed embryos were washed in methanol and stained in 0.2 mg ml−1 alcian blue
in 75% ethanol, 25% glacial acetic acid overnight. Embryos were made
transparent in Murray's clear and viewed by stereo-microscope.mesoderm that has yet to segment. (D) In the late tailbud (stage 32) embryo,
expression is predominantly within the head in the branchial arches (Ba) and
eyes. (E) Planar longitudinal section through a tailbud embryo (posterior to
the top) showing the expression of SMRT in the somites (Sm) and in the floor
plate (Fp) of the posterior neural tube. (F) Highlighting the nuclei within the
cells of a somite using Hoechst stain shows that SMRT mRNA has a
perinuclear distribution (arrowed).Results
The corepressor SMRT is expressed predominantly in neural
tissue and somites during Xenopus development
RT-PCR shows that SMRT is expressed throughout devel-
opment, but with decreased expression in the late gastrula, early
neurula embryo (Koide et al., 2001; Malartre et al., 2004). In
situ hybridization with Xenopus SMRT RNA probes shows that
the gene is expressed throughout the ectoderm of the gastrula
embryo (Figs. 1A, B). By the tailbud stage, expression is
predominantly in head and somites (Fig. 1C). A little later (stage
32), expression within the head is more defined and is found in
the neural tube and branchial arches, but there is less in the
epidermis and somites (Fig. 1D). Planar sections at the tailbud
stage show that the banding pattern in the early somites is due to
the perinuclear localization of SMRT transcripts (Fig. 1F), an
organization previously reported for other nuclear proteins
(Orford et al., 1998; Hyde and Old, 2000). In addition, SMRT
expression is seen in posterior, but not anterior, floor plate of the
neural tube (Figs. 1C, E).
Alternative splicing of Xenopus SMRT during the early
developmental stages
The inclusion of exon 37b introduces a third CoRNR box
into SMRT, which shows distinct sequence homology to
CoRNR box 3 of NCoR (Malartre et al., 2004). To examine
SMRT alternative splicing, we first looked at the expressionpatterns of transcripts with and without exon 37b (37b+/−) and
compared these to the expression patterns of exon 44b. The
alternative splicing of exons 37b and 44b (Fig. 2A) is conserved
from frog to mouse (Malartre et al., 2004). The inclusion of
exon 44b alters critical sequence adjacent to CoRNR box 1
(Cohen et al., 2001; Hu et al., 2001; Makowski et al., 2003;
Malartre et al., 2004) and directly affects interactions of SMRT
with transcription factors (Goodson et al., 2005).
Exon 37b(+) and exon 37b(−) transcripts have similar
temporal patterns of expression, both showing a decrease in
transcript levels across the neurula stages (Fig. 2B). In contrast,
exon 44b(+) is more abundant than 44b(−) at each stage of
development. SMRT 37b(+) and (−) transcripts are found in all
tissues at the gastrula stage, though the 37b(−) form seems more
abundant in tissue from the poles than the 37b(+) isoform (Fig.
2C). SMRT 44b(+) transcripts are also found throughout the
embryo, though 44b(−) transcripts are not detectable at this
stage (Fig. 2C). The equivalent levels of 37b(+) and (−)
transcripts through development and the observation that 37b
(+) encodes the additional CoRNR box, identified this splicing
event as a good subject for functional analysis. In diagnostic
tissues isolated from the swimming tadpole (stage 40) (Fig. 2D),
the ratio of exon 37b(+) to (−) isoforms is essentially constant.
Fig. 2. The developmental expression of SMRT exon 37b and 44b isoforms. (A) Exons 37/37b and 44/44b of xSMRT both use an upstream and a downstream splice
donor. Use of the downstream donor in exon 37 results in the inclusion of exon 37b, which encodes a third SMRT CoRNR box (black bar). The CoRNR box in exon 44
is close to the upstream donor and alternative splicing will vary the sequence flanking the CoRNR box. (B) RT-PCR showing that exon 37b(+) and (−) transcripts are
expressed with similar dynamics during early development. Exon 44b(+) transcripts are more abundant than the 44b(−) form at all stages of early development. ODC is
a control for cDNA levels. (C) In dissections of gastrula (stage 10) embryos, exon 37 transcripts are found in all samples though exon 37b(−) transcripts are equally
over-represented in animal caps and vegetal pole regions compared to the ODC control. The cDNA is taken from equal numbers of embryo parts and so the marginal
zones (dz and vz) will contain more cells and this is reflected in the ODC levels. Exon 44b(+), but not 44b(−) transcripts are detected at the gastrula stage and are also
distributed throughout the embryo. ac, animal cap; dz, dorsal marginal zone; vz, ventral marginal zone; vg, vegetal piece. (D) In the swimming tadpole (stage 40), exon
37b(+) and (−) transcripts are approximately equally expressed in each tissue examined. Although exon 44b(−) transcripts are not detected in the brain, both isoforms
are found in the other tissues examined. sz, size markers; br, brain; sm, somites; in, intestine; ey, eye; wh, whole embryo.
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all but the brain, where, compared to somites, the 44b(−) form is
under-represented (Fig. 2D). Consequently, there is little
evidence for extensive tissue-specific alternative splicing of
the individual exons 37b and 44b in the embryo.
Changes in the profile of SMRT transcripts during development
We have previously identified four sites of alternative
splicing in Xenopus SMRT and characterized five major
transcripts that constitute the SMRT profile in blastulae
(Malartre et al., 2004). Eleven transcripts are identified at
stage 30 and all sixteen potential SMRT transcripts are seen at
stage 40 (Fig. 3A). The three predominant transcripts at this
stage (Fig. 3B) are 37b(−)/41(+)/42b(+)/44b(+) [SMRT C], 37b
(−)/41(+)/42b(+)/44b(−) [SMRT I] and 37b(−)/41(−)/42b(+)/
44b(+) [SMRT J]. It is clear that the complexity of the repertoire
of SMRT transcripts increases as the embryo develops and
transcripts such as 37b(−)/41(−)/42b(+)/44b(−) [SMRT O] and
37b(−)/41(−)/42b(−)/44b(−) [SMRT P], which were notapparent at the blastula stage, make a major contribution in
the swimming tadpole (Fig. 3C).
An antisense MO can be used to dictate the splicing decision at
exon 37b
To determine whether changes to the pattern of alternative
splicing of SMRT affect development, we generated embryos
that do not incorporate exon 37b and which are therefore limited
to the 2-box isoforms of SMRT. Embryos were injected with a
morpholino oligonucleotide (MO37b) complementary to the
37b splice donor junction of diploid Xenopus tropicalis (JGI,
Xenopus topicalis genome project). At the stages examined, the
profiles of SMRT transcript isoform expression in X. tropicalis
and X. laevis are identical (data not shown). When injected into
X. tropicalis, MO37b inhibits the inclusion of exon 37b and
instead promotes splicing from the internal exon 37 donor (Fig.
4A) and the same result is seen using X. laevis (data not shown).
Bands corresponding to 37b(+) and 37b(−) transcripts are seen
in uninjected controls, but 37b(+) transcripts are undetectable in
Fig. 3. The developmental profile of SMRT transcript isoforms changes during development. (A) Profile from the tailbud (stage 30) embryo identifies eleven major
transcripts. Red arrows indicate the five major transcripts previously identified at the blastula stage (Malartre et al., 2004). The exonic structure of the transcripts is
shown diagrammatically with alternatively spliced exons numbered and colored blue. The three SMRT CoRNR boxes are shown as yellow stripes, CoRNR box 2 is
split between exons 39 and 40. Isoforms are labeled A to P in descending size order. In the swimming tadpole (stage 40) all 16 isoforms are identified. An extended
view of the gel (outer lane) shows the lack of additional isoforms. (B) The approximate level of each transcript at stage 40 was quantified on a phosphorimager from
three independent reactions and the mean and standard deviations presented in the graph. Isoforms C, I and J are consistently the major expressed forms (P N 0.001
one-way ANOVA followed by Tukey's pairwise comparison). The dotted line marks the 6.25% expression level expected for 16 equally expressed isoforms. (C) The
sixteen isoforms of SMRT are represented as boxes at three stages of development. Filled boxes denote expression. At stage 6 the five expressed isoforms all
contain exon 44b+, whereas 44b− isoforms are the last to be added to the profile.
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(Fig. 4B, panel 1) but primers specific for exon 37b detect
transcripts in uninjected controls only (Fig. 4B, panel 2) while a
primer annealing specifically to the correctly spliced exon 37/38
junction (indicative of true SMRT 37b(−) transcripts) generatesa single band of predicted length. The lack of additional bands
demonstrates the integrity of splicing at this site (Fig. 4B, panel
3). Quantitative RT-PCR on tailbud stage Xenopus laevis
embryos injected with either one of two control morpholino
oligonucleotides, C1 and C2, or MO37b demonstrated a large
Fig. 4. An antisense MO approach to bias alternative splicing decisions. (A) The antisense MO37b (black bar, MO) spans the X. tropicalis exon 37b exon splice donor
sequence and inhibits formation of the 37b(+) transcript. However, splicing from the upstream internal exon 37 donor is unaffected giving the 37b(−) transcript. (Small
arrows, PCR primers used in B; black bar, CoRNR box-3). (B) RT-PCR analysis of an uninjected (U) and eight individual X. tropicalis embryos (a–h) injected with
MO37b demonstrates the loss of the 37b(+) transcript (panel 1) when analyzed at the late tailbud stage. The loss of the upper band is not accompanied by the formation
of additional bands indicating the lack of aberrant splicing. The lack of the 37b(+) SMRT transcript is confirmed by a specific RT-PCR (panel 2). Identical patterns
were seen in 27/28 embryos taken from 3 independent experiments. Panel 3 shows that 37b(−) transcripts are correctly formed in the injected embryos. ODC in panel 4
is used as a loading control. (C) Injection of MO37b depletes 37b containing transcripts but does not affect the total level of SMRT transcripts. Xenopus laevis embryos
were injected with 30 ng of either MO37b, or two different control morpholino oligonucleotides, C1 and C2 that do not interact with SMRT transcripts. The level of
transcripts containing exon 37b and exon 37 were measured by quantitative RT-PCR and the fold change of 37b(+) or 37 transcripts in MO37b to control morpholino-
injected embryos calculated. There is no significant change in total SMRT (37) transcripts but a greater than 60-fold decrease in 37b transcripts. The lack of change in
exon 37 transcripts suggests that depletion of exon 37b(+) transcripts does not significantly affect the total level of SMRT mRNA. (D) RT-PCR across the alternatively
spliced downstream exons 41 and 42 are unaffected by MO37b. Within the accuracy of the protocol there is no significant change in the level of SMRT transcripts
between uninjected (U) and MO37b (MO)-injected embryos. (E) Time course of depletion of 37b(+), but not 37b(−) transcripts from MO37b-injected embryos.
Injection of the MO eliminates the formation of zygotic SMRT 37b(+) transcripts from pre-mRNA, but does not affect transcripts that are already processed. Assaying
for 37b(+) transcripts across a developmental series indicates that processed, oocyte-derived transcripts persist in the neurula (st 16) (top panel). SMRT 37b(−)
transcripts are unaffected by the MO (lower panel). U, uninjected; b, blastula; g, gastrula; n, neurula; et, early tailbud; lt, late tailbud; sz, size markers.
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However, no significant change in the level of constitutively
spliced exon 37 transcripts, indicative of SMRT transcripts as a
whole, was found between control and MO37b-injected
embryos (Fig. 4C). RT-PCR using primers that span the
alternatively spliced exons 41 or 42 indicates that the splicing
of these exons is unaffected by the depletion of exon 37b(+)
transcripts by MO37b (Fig. 4D). These results demonstrate that
MO37b depletes 37b(+) transcripts without significant affect on
the overall level of SMRT mRNA or bias to downstream
alternative splicing events.
It is unlikely that oocyte-derived SMRT37b(+) mRNA,
present in the early embryo, will be affected by MO37b as this
population of SMRT transcripts will be processed during
oogenesis, before injection of the oligonucleotide. However, the
persistence of oocyte-derived SMRT37b(+) transcripts will
affect the stage at which a morpholino-dependent phenotype
will appear. To follow their persistence, the presence of X.
tropicalis 37b(+) transcripts was assayed by RT-PCR afterMO37b injection. Transcripts are prevalent in gastrulae, less
abundant in neurulae, but undetectable by the early tailbud stage
(Fig. 4E). Oocyte-derived SMRT37b(+) transcripts are therefore
present while the neural tube is patterned during the gastrula and
neurula stages and associated SMRT 3-box protein may persist
for longer. A phenotypic response to MO37b injection,
therefore, is not expected at these stages and may only be
apparent in a later embryo.
Depletion of SMRT 37b(+) transcripts compromises the
expression of thyroid hormone-responsive genes
The injection of nanogram amounts of morpholino oligonu-
cleotide antisense to sequences surrounding the start codon of
an mRNA has been reported to block translation (Heasman et
al., 2000; Nutt et al., 2001). Similarly, nanogram amounts of
oligonucleotide can cause a gene knockdown by disrupting pre-
mRNA splicing and as this can be quantified, by the loss of
transcript, the efficacy of the process can be determined without
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the effectiveness of morpholino oligonucleotides to dictate
productive alternative splicing has not been reported. To
evaluate MO37b, we examined the ability of different amounts
of the oligonucleotide to eliminate 37b(+) transcripts at the
tailbud stage. The majority of exon 37b(+) transcripts are
eliminated by the injection of 3 ng of MO37b. Additional
amplification (a total of 36 cycles) indicates that between 15 and
30 ng of MO37b are necessary to inhibit 37b(+) formation
completely (Fig. 5A).
We examined the expression, in tailbud X. tropicalis
embryos, of ten genes downstream of transcription factors
known to interact with SMRT. Expression of none of four
retinoid-responsive, a PPAR-responsive or an SRF-responsiveFig. 5. MO37b affects expression of TH but not RA-responsive genes. (A)
Titration of MO37b. Injection of 3 ng of the antisense MO37b causes a major
depletion of 37b(+) transcripts but 30 ng is required for a complete depletion.
37b(−) transcript levels were unaffected. This correlates with the observation
that it is necessary to inject 15–30 ng of MO37b to see a phenotype. (B) RT-PCR
using primers for PPARγ, SRF and four retinoid-responsive genes (RAR) show
no major change in expression following the elimination of SMRT 37b(+)
isoforms. However, four thyroid hormone-responsive genes (THR) each show a
decrease in expression following the injection of sufficient MO37b to cause a
visible phenotype.gene is affected by the depletion of SMRT 37b(+) transcripts
(Fig. 5B). However, each of four thyroid hormone-responsive
genes had reduced transcript levels in response to SMRT 37b(+)
depletion (Fig. 5B).
Injection of the MO37b produces a phenotype in late tailbud
embryos
Injection of 3 ng to 30 ng of MO37b generates X. tropicalis
and X. laevis embryos with a superficially normal body plan.
However, all injected embryos (X. tropicalis, n = 80; X. laevis,
n = 25) fail to swim normally at the tailbud stage (stage 32),
indicating a defect in neural or muscular development. X.
tropicalis embryos injected with 30 ng of MO37b, which
therefore had undetectable levels of 37b(+) transcripts, showed
normal morphology and expression patterns for the general
neural marker, sox2 (Figs. 6A, B) and the regional neural
markers engrailed and krox-20 (data not shown) at the late
neurula stage. By the tailbud stage, MO37b-injected X.
tropicalis (Fig. 6C) and X. laevis (Figs. 6D, E) embryos
developed with a bent A–P axis and shortened heads. At later
stages the head became irregular in shape particularly in the
anteriormost region (Figs. 6F, G X. tropicalis; J, K X. laevis) and
when stained with the anti-HNK1 antibody, which in Xenopus
identifies neural structures, gave additional staining in the
olfactory epithelium (Figs. 6H, I X. tropicalis; L, M X. laevis).
In addition, anti-HNK1 staining in the trunk region showed
the extensive disorganization of sensory and motor axon tracts
proximal to the neural tube in MO37b-injected X. tropicalis
embryos (Figs. 7A, B), which may explain observed defects in
co-ordinated swimming. By the swimming tadpole (stage 40)
the heads of MO37b-injected X. tropicalis individuals were
smaller than normal and Alcian Blue staining identified cranial
neural crest derived cartilage elements, including the gill arches,
ethmoid plate, ceratohyale and Meckel's cartilage that were
compacted and thickened compared to controls (Figs. 7C, D).
The injection of MO37b therefore has no discernible effect on
development up to the late neurula stage but generates a range
of defects at the tailbud and swimming tadpole stages.
Discussion
SMRT and NCoR are paralogues that act as corepressors for
a range of transcription factors. We have previously shown that
SMRT, unlike NCoR, is subject to extensive alternative splicing
in the region of the gene that encodes the carboxy-terminal
interaction domains (Malartre et al., 2004; Short et al., 2005).
One event introduces exon 37b into the mRNA and results in
the inclusion of a third CoRNR box in this region of the protein.
The generation of isoforms by alternative splicing will increase
the size of the proteome and it has been suggested that this may
compensate for the relatively small number of genes in higher
organisms (Black, 2000; Graveley, 2001; Maniatis and Tasic,
2002). It is implied that isoforms will possess distinct activities
and this has been shown for a number of genes (e.g.,
fibronectin, Muro et al., 2003; fruitless, Heinrichs et al., 1998;
cell surface protein Dscam, Wojtowicz et al., 2004). The heart
Fig. 6. Injection of MO40b affects olfactory placode, axonal and cranial differentiation. (A and B) In situ hybridization of early tailbud (stage 24) X. tropicalis embryos
with an antisense sox2 probe. Staining is within the neural tube and there is no difference between (A) uninjected and (B) MO37b (15 ng) injected embryos. (C) Lateral
view of uninjected (upper) and MO37b-injected (lower) X. tropicalis embryos at the swimming tadpole stage. (D and E) X. laevis embryos injected with either 30 ng
control MO (D) or 30 ng of MO37b (E). The gross phenotype of the MO37b X. tropicalis and X. laevis is identical and consists of a kinked axis and shortened head. (F
and G) Dorsal view of the heads of X. tropicalis embryos injected with either 3 ng (F) or 30 ng (G) of MO37b. Injection of the higher doses was required to eliminate all
37b(+) transcripts and resulted in the irregular head phenotype (arrowed) in more than 90% of cases, n = 50. (H and I) Dorsal view of swimming tadpole (stage 36) (H,
normal and I, MO37b injected) stained with the anti-HNK1 antibody and photographed in Murray's Clear showing the expanded differentiation of the olfactory
epithelium (p) (arrowed). General head development is also compromised in these. (J and K) Dorsal view of the heads of X. laevis embryos injected with 30 ng of
control MO (J) or 30 ng MO37b (K) again indicating the irregular head phenotype in the MO37b-injected embryo (arrowed). (L and M) Frontal view of X. laevis
embryos stained with HNK-1 to show the expanded olfactory epithelium (arrowed) in MO37b-injected (M) compared to control MO-injected (L) embryos.
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regulates a small number of alternative splicing events, results
in severe cardiomyopathy confirming the importance of
alternative splicing in development (Xu et al., 2005). In this
paper, we examine the expression pattern of SMRT transcripts
containing exon 37b, which encode the 3-box SMRT isoforms
and use an antisense morpholino oligonucleotide to dictate the
outcome of SMRT alternative splicing in Xenopus embryos.
There are several mechanisms of alternative splicing (Black,
2003; Caceres and Kornblihtt, 2002). In Xenopus SMRT, three
of the four alternative splicing events in the 3′ region (exons
37b, 42b and 44b) involve readthrough of a splice donor and the
subsequent use of a downstream site (Malartre et al., 2004), a
mechanism that is frequently used for other alternatively splicedtranscripts. Morpholino oligonucleotides have been used to
knockdown gene expression by targeting them to the start codon
(Heasman et al., 2000; Nutt et al., 2001) or by disrupting pre-
mRNA splicing (Draper et al., 2001). In the latter case, a
common strategy is to design a MO antisense to a splice donor,
which efficiently blocks splicing at that site, causing aberrant
splicing from an upstream cryptic splice donor. Recently, a
morpholino oligonucleotide has been used to eliminate the exon
encoding the transmembrane domain of the fish gene heart of
glass to confirm its predicted role in heart growth (Mably et al.,
2003). When alternative splicing involves the readthrough of
one donor, as seen in SMRT exon 37b, we have shown that
inhibiting splicing at the downstream donor accurately
promotes the use of the appropriate upstream site rather than
Fig. 7. Injection of MO37b disrupts axon tracts and head morphology. (A and B)
Lateral view of anti HNK-1 stained X. tropicalis embryos (stage 36) showing the
formation of peripheral neural tracts (arrowed) in uninjected (A) and MO37b-
injected embryos (B). In normal embryos the tracts follow a distinct pathway
and the axons are bundled whereas in the injected embryos the pathways are
disorganized and the axons dispersed. (C and D) Ventral view of stage 42
uninjected (C) and MO37b (D) injected X. tropicalis embryos stained with
alcian blue to identify cranial cartilaginous elements. The gill arches (g),
ethmoid plate (adjacent to line), ceratohyale (arrowed) and Meckel's cartilage
(m) can be identified in both embryos but are thickened and compressed in
injected embryos (n = 9).
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knockdown approach and in contrast to the conventional use of
morpholino oligonucleotides, which do not affect transcript
levels, the effectiveness of MO37b can be followed at the level
of transcription without the need for specific antibodies.
Furthermore, this approach has the potential to dictate the
outcome of splicing at any exon that uses alternative splice
donors.
SMRT and NCoR interact with a range of transcription
factors and the CoRNR boxes mediate interactions with nuclear
receptors including RARα and the thyroid hormone receptor
(Hu and Lazar, 1999; Perissi et al., 1999; Hu et al., 2001).
SMRT, acting through retinoid receptors has been implicated in
Xenopus head development (Koide et al., 2001) while the
conserved CoRNR box-3, at least in NCoR, has been shown to
bind preferentially to THR. Consequently, we examined the
effects of MO37b primarily on genes regulated by retinoic acid
and thyroid hormone. The elimination of box-3 containing
transcripts reduces the expression of four targets of thyroid
hormone signaling but does not affect six targets of retinoid,PPARγ and SRF signaling. It is therefore clear that depleting
SMRT 37b(+) transcripts affects specific target genes in vivo.
However, it is perhaps contrary to expectation to observe a
reduction, rather than an increase, in thyroid-responsive gene
transcripts following the loss of corepressor isoforms.
Although SMRT has been reported to have coactivator activity
in some promoter contexts (Berghagen et al., 2002) it is
unlikely for TR beta and THbzip promoters as ChIP analysis
has shown SMRT to be displaced from these when activated by
hormone (Tomita et al., 2004). One possibility is that the loss
of 37b(+) isoforms lifts inhibition of expression from another
repressor, which in turn inhibits these genes. This type of
mechanism has been proposed for SMRT/MeCP2 mediated
inhibition of the neuronal repressor hairy 2A (Stancheva et al.,
2003). As MO37b alters the profile of SMRT isoforms without
affecting the level of SMRT transcripts in total, another
possibility is that the increase in SMRT isoforms without
CoRNR box 3 allows these to bind to thyroid hormone-
responsive promoters and act as stronger corepressors than
isoforms containing CoRNR box 3. Maintaining a balance
between corepressors and coactivators in a cell contributes to
gene expression (Perissi and Rosenfeld, 2005), using MO37b
will result in the expression of SMRT isoforms with different
affinities for nuclear receptors that may alter the established
balance, resulting in the enhanced repression of thyroid
hormone-responsive genes.
Following injection of the MO37b morpholino oligonucle-
otide, SMRT 37b(+) transcripts are undetectable after the late
neurula stage. The 37b(+) transcripts found prior to this are
most likely to be processed transcripts laid down in the oocyte
and the associated SMRT 3-box proteins may be expected to
persist at least until the late neurula stage. Consequently, a
depletion phenotype would not be seen until the tailbud stage or
later and indeed, neurula stage embryos are morphologically
indistinguishable from controls and have normal expression
patterns for a number of marker genes. Dictating the exon 37b
splicing decision produces swimming tadpoles with an enlarged
olfactory epithelium, altered cranial morphogenesis and paral-
ysis, the latter probably due to disorganized outgrowth of
sensory and motor neurones. SMRT 37b(+) isoforms may be
interacting with thyroid hormone receptors (TRs) and trans-
genic Xenopus embryos expressing a dominant negative form of
the TR that binds corepressor constitutively show reduced cell
proliferation in the olfactory epithelium and nasal region
(Schreiber et al., 2001).
Alternative splicing generates a range of related protein
isoforms from one gene and may permit the refinement of
activity such that each isoform is adapted to a specific function.
Of the paralogous corepressors, SMRT and NCoR, only SMRT
undergoes extensive alternative splicing in the region of the
transcript that encodes the domains that interact with nuclear
receptors. The production of SMRT isoforms is temporally and
spatially regulated during development. Elimination of one of
the alternative spliced exons, which encodes a transcription
factor interaction domain, affects transcription from thyroid
hormone but not retinoid-responsive genes and generates
Xenopus embryos with a range of specific defects. These
342 M. Malartre et al. / Developmental Biology 292 (2006) 333–343results suggest that the regulated alternative splicing of SMRT
isoforms is necessary for normal development.
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